Literature DB >> 6271966

A gouty family with increased phosphoribosylpyrophosphate synthetase activity: case reports, familial studies, and kinetic studies of the abnormal enzyme.

I Akaoka, S Fujimori, N Kamatani, F Takeuchi, E Yano, Y Nishida, A Hashimoto, Y Horiuchi.   

Abstract

Two male patients with urate overexcretion and clinical gout in a family showed activity of phosphoribosylpyrophosphate (PRPP) synthetase in erythrocyte lysates (3.1-fold) greater than that found in normal subjects. Hemolysates from 5 female persons in this family contained (2.7-fold) increased enzyme activity suggesting X-linked dominant transmission of the abnormality. Increased maximal velocity of the enzyme, aberrant protein pattern in polyacrylamide electrophoresis, and increased thermolability in purified enzyme suggested that this enzyme is a mutant one. From these findings, it was assumed that the characteristics of this enzyme were different from 4 previously reported enzymes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271966

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  PRPS1 mutations: four distinct syndromes and potential treatment.

Authors:  Arjan P M de Brouwer; Hans van Bokhoven; Sander B Nabuurs; Willem Frans Arts; John Christodoulou; John Duley
Journal:  Am J Hum Genet       Date:  2010-04-09       Impact factor: 11.025

2.  Rapid method for the diagnosis of partial adenine phosphoribosyltransferase deficiencies causing 2,8-dihydroxyadenine urolithiasis.

Authors:  F Takeuchi; K Matsuta; T Miyamoto; S Enomoto; S Fujimori; I Akaoka; N Kamatani; K Nishioka
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 3.  Clinical and biochemical aspects of uric acid overproduction.

Authors:  J García Puig; F A Mateos
Journal:  Pharm World Sci       Date:  1994-04-15

4.  The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity.

Authors:  M A Becker; P R Smith; W Taylor; R Mustafi; R L Switzer
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Selective expression of phosphoribosylpyrophosphate synthetase superactivity in human lymphoblast lines.

Authors:  M J Losman; D Rimon; M Kim; M A Becker
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  The mode of genetic transmission of gouty family with increased phosphoribosylpyrophosphate synthetase activity.

Authors:  F Takeuchi; F Hanaoka; E Yano; M Yamada; Y Horiuchi; I Akaoka
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

Review 7.  New developments in the epidemiology and genetics of gout.

Authors:  Raihana Zaka; Charlene J Williams
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

Review 8.  Association of PRPS1 Mutations with Disease Phenotypes.

Authors:  Rahul Mittal; Kunal Patel; Jeenu Mittal; Brandon Chan; Denise Yan; M'hamed Grati; Xue Zhong Liu
Journal:  Dis Markers       Date:  2015-05-24       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.